Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Oskarsson, Oskar Orn
MetadataShow full item record
CitationJ. Exp. Med. 2005, 201(1):117-25
AbstractInflammation can predispose to myocardial infarction (MI), and mannan binding lectin (MBL) promotes phagocytic clearance of inflammatory agents, but the predictive value of MBL levels for MI is not known. MBL was analyzed in subgroups of the population-based Reykjavik study, a cohort of 19,381 participants recruited from 1967. MBL levels were very stable over time (self correlation: 0.86). In a cross-sectional group from the original cohort (n = 987), high MBL (>1,000 microg/L) was associated with a greatly lowered odds ratio for MI (0.64, P < 0.001). To verify this finding, a nested case control sample (n = 1,309) was randomly selected from the cohort. High MBL at recruitment was also associated with decreased MI risk in this follow-up group, but to a lesser extent and not significant for the whole group, smokers, or hypertensive individuals. However, high MBL was as in the cross-sectional group, associated with greatly decreased MI risk in diabetic (P = 0.02) or hypercholesterolemic individuals (P = 0.004). This also applied to raised erythrocyte sedimentation rate (P = 0.007). Diabetic patients with high MBL did not have a higher MI risk than nondiabetic individuals. Our findings indicate that high MBL may predict decreased likelihood of MI, particularly in diabetics, and are consistent with the possibility that MBL may promote clearance of atherogenic agents.
DescriptionTo access full text version of this article. Please click on the hyperlink "View/Open" at the bottom of this page
To access publisher version of this article. Please click on the hyperlink in Additional Link field
- Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
- Authors: Migliaresi P, Celentano A, Palmieri V, Pezzullo S, Martino S, Bonito M, Guillaro B, Brancati C, Di Minno G
- Issue date: 2007 Jul
- Measurement of serum levels of mannose-binding lectin in hemodialysis patients: a comparison with healthy individuals.
- Authors: Akbari R, Mireskandari M, Alizadeh-Navaei R, Ghods A
- Issue date: 2011 Jul
- Mannose-binding lectin as a risk factor for acute coronary syndromes.
- Authors: Pesonen E, Hallman M, Sarna S, Andsberg E, Haataja R, Meri S, Persson K, Puolakkainen M, Ohlin H, Truedsson L
- Issue date: 2009
- Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
- Authors: Schoepfer AM, Flogerzi B, Seibold-Schmid B, Schaffer T, Kun JF, Pittet V, Mueller S, Seibold F
- Issue date: 2009 Oct
- Mannose-binding lectin and mortality in type 2 diabetes.
- Authors: Hansen TK, Gall MA, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A
- Issue date: 2006 Oct 9